No. of Pages: 107 | Report Code: TIPRE00018223 | Category: Life Sciences
Les dispositifs mécaniques percutanés d\'assistance circulatoire offrent une approche efficace et rapide pour ralentir la spirale descendante de l\'instabilité hémodynamique chez les patients souffrant de décompensation. insuffisances cardiaques et chocs cardiogéniques jusqu\'à ce qu\'une stratégie plus définitive soit perçue parmi les patients pour se remettre de ces maladies cardiaques. Les principaux rôles des dispositifs d\'assistance circulatoire mécanique percutanée comprennent l\'amélioration du débit cardiaque natif, la réduction du volume ventriculaire et des pressions de remplissage, l\'augmentation de la perfusion coronarienne et le maintien de la perfusion des organes vitaux.
Le marché européen des dispositifs mécaniques d\'assistance circulatoire percutanée devrait atteindre 1 199,73 millions de dollars américains d\'ici 2027, contre 456,73 millions de dollars américains en 2019. Le marché devrait croître à un TCAC de 13,1 % entre 2019 et 2027.L\'augmentation de la population gériatrique, la prévalence croissante des maladies cardiovasculaires et la pénurie de donneurs de cœur sont les principaux facteurs qui devraient stimuler la croissance du marché des dispositifs mécaniques percutanés d\'assistance circulatoire en Europe. Cependant, le marché sera probablement impacté par les coûts élevés de ces dispositifs et des procédures qui leur sont associées, ainsi que par les rappels de produits et l\'impact de la pandémie de COVID-19 sur l\'industrie des dispositifs médicaux au cours de la période de prévision.
En termes de produit, le segment des pompes à ballonnet intra-aortique (IABP) représentait la plus grande part du marché européen des pompes circulatoires mécaniques percutanées. marché des dispositifs d\'assistance circulatoire mécanique en 2019. En termes d\'utilisateurs finaux, le segment des hôpitaux représentait la plus grande part du marché européen des dispositifs d\'assistance circulatoire mécanique percutanée en 2019.
Plusieurs sources primaires et secondaires majeures associées au rapport sur le marché européen des dispositifs mécaniques d\'assistance circulatoire percutanée sont l\'Organisation mondiale de la santé (OMS), le Réseau cardiaque européen, les Services nationaux de santé (NHS), les Centers for Disease. Control and Prevention (CDC), British Heart Foundation, Société européenne de cardiologie et autres.
Strategic insights for Europe Percutaneous Mechanical Circulatory Support Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 456.73 Million |
| Market Size by 2027 | US$ 1,199.73 Million |
| Global CAGR (2019 - 2027) | 13.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Produit
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
The regional scope of Europe Percutaneous Mechanical Circulatory Support Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Percutaneous Mechanical Circulatory Support Devices Market is valued at US$ 456.73 Million in 2019, it is projected to reach US$ 1,199.73 Million by 2027.
As per our report Europe Percutaneous Mechanical Circulatory Support Devices Market, the market size is valued at US$ 456.73 Million in 2019, projecting it to reach US$ 1,199.73 Million by 2027. This translates to a CAGR of approximately 13.1% during the forecast period.
The Europe Percutaneous Mechanical Circulatory Support Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Percutaneous Mechanical Circulatory Support Devices Market report:
The Europe Percutaneous Mechanical Circulatory Support Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Percutaneous Mechanical Circulatory Support Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Percutaneous Mechanical Circulatory Support Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Percutaneous Mechanical Circulatory Support Devices Market
